Thermo Fisher Scientific Inc. (NYSE: TMO) today announced that it has acquired Priority Solutions International, a leading third-party logistics provider to the pharmaceutical and healthcare industries, following anti-trust clearance. Priority Solutions was previously majority-owned by Arsenal Capital Partners. With revenues of approximately $95 million in 2006, Priority Solutions offers a comprehensive range of services for the delivery of FDA-regulated pharmaceuticals, including shipment of pharmaceutical samples, direct-to-physician patient supplies, and pharmaceutical warehousing and order fulfillment.
Priority Solutions will be integrated into Thermo Fisher's biopharma services business, which includes the packaging and delivery of tightly regulated pharmaceutical samples to patients participating in clinical trials.
"The addition of Priority Solutions will make our biopharma services business an even stronger partner for biotechnology and pharmaceutical customers who are increasingly looking to outsource clinical trials management," said Marijn E. Dekkers, president and chief executive officer of Thermo Fisher Scientific. "This acquisition brings tremendous logistics expertise and an infrastructure to our existing outsourcing services that strengthens our ability to deliver pharmaceutical supplies to the right people at the right time - anywhere in the world."
Based in Swedesboro, New Jersey, Priority Solutions' non-asset-based logistics network extends to more than 500 cities worldwide. From order entry to final delivery, Priority Solutions tracks, manages and reports shipment status through call center specialists and a variety of Web-based tools available to both vendors and clients. Throughout the process, each step is fully documented to ensure end-to-end integrity of shipments in the highly regulated pharmaceutical and healthcare industries.
